These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9230649)

  • 1. Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.
    Warnock JK; Bundren JC
    Psychopharmacol Bull; 1997; 33(2):311-6. PubMed ID: 9230649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.
    Warnock JK; Bundren JC; Morris DW
    Biol Psychiatry; 1998 Mar; 43(6):464-5. PubMed ID: 9532352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms associated with gonadotropin-releasing hormone agonists.
    Warnock JK; Bundren JC; Morris DW
    Depress Anxiety; 1998; 7(4):171-7. PubMed ID: 9706454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GnRH agonists: gonadorelin, leuprolide and nafarelin.
    Pace JN; Miller JL; Rose LI
    Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
    Hansen LM; Batzer FR; Corson SL; Bello S
    J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
    Bedaiwy MA; Mousa NA; Casper RF
    Fertil Steril; 2009 Apr; 91(4 Suppl):1574-7. PubMed ID: 18973892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity vasculitis associated with leuprolide (Lupron).
    Gnanaraj J; Saif MW
    Cutan Ocul Toxicol; 2010 Sep; 29(3):224-7. PubMed ID: 20470239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T; Sakata M; Terakawa N
    Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist.
    Steingold KA; Cedars M; Lu JK; Randle D; Judd HL; Meldrum DR
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):403-11. PubMed ID: 2950349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell growth effects of leuprolide on cultured endometrioma cells.
    Levine D; Kaufman L; Cuenca VG; Badawy SZ
    J Reprod Med; 2007 Jul; 52(7):581-4. PubMed ID: 17847754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice.
    Umathe SN; Bhutada PS; Jain NS; Shukla NR; Mundhada YR; Dixit PV
    Neuropeptides; 2008 Aug; 42(4):399-410. PubMed ID: 18533256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GnRH-agonists in the therapy of endometriosis].
    Hoffmann G; Spitz J; Behrens R
    Ther Umsch; 1990 Dec; 47(12):937-44. PubMed ID: 2128966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for add-back with gonadotrophin-releasing hormone agonist therapy.
    Studd J; Leather AT
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():1-4. PubMed ID: 8916978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary endometriosis with a long-acting GnRH agonist.
    Seltzer VL; Benjamin F
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):929-31. PubMed ID: 2120647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy].
    Ruwe M; Donhuijsen K; Regidor PA; Leder LD; Schindler AE
    Zentralbl Gynakol; 1998; 120(8):391-8. PubMed ID: 9757546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GnRH agonist and add back therapy--indications, results and problems in the treatment of genital endometriosis].
    Mettler L
    Zentralbl Gynakol; 2003; 125(7-8):267-75. PubMed ID: 14505262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone agonist inhibits estrone sulfatase expression of cystic endometriosis in the ovary.
    Maitoko K; Sasaki H
    Fertil Steril; 2004 Aug; 82(2):322-6. PubMed ID: 15302278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sertraline in the treatment of mixed anxiety and depression disorder].
    Carrasco JL; Díaz-Marsá M; Sáiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(3):141-5. PubMed ID: 9381956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.